| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |